B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice

Diabetes

Volumn 46, Issue 6, 1997, Pages 941-946

  Noorchashm, Hooman ^a   Noorchashm, Negin ^a   Kern, Joshua ^a   Rostami, Susan Y ^a   Barker, Clyde F ^a   Naji, All ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOPATHOGENESIS; INSULITIS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; SIALOADENITIS; SPLEEN CELL;

EID: 0030969531     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.6.941     Document Type: Article

References (42)

1. Kikutani H, Makino S: The marine autoimmune diabetes model: NOD and related strains. Adv in Immun 51:285-322, 1992
2. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 366:72-75, 1993
3. Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in marine insulin-dependent diabetes. Nature 366:69-72, 1993
4. Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F: Non-obese diabetic mice: immune mechanisms of pancreatic β cell destruction. Diabetologia 27:113-115, 1984
5. Yokono K, Shii K, Yaso S, Ejiri K, Ishihara K, Fujii S, Kazumi T, Taniguchi H, Baba S: Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice. Diabetologia 26:379-385, 1984
6. Postesilli M, Carotenuto P, Gazda LS, Pratt PF, Prowse SJ: Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study. Clin Exp Immun 70:84-93, 1987
7. Serreze DV, Leiter EH: Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J Immun 140:3801-3807, 1988
8. Michel C, Boitard C, Bach JF: Insulin autoantibodies in non-obese diabetic (NOD) mice. Clin Exp Immunol 75:457-460, 1989
9. Ziegler AG, Vardi P, Ricker AT, Hattori M, Soeldner JS, Eisenbarth GS: Radioassay determination of insulin autoantibodies in NOD mice: correlation with increased risk of progression to overt diabetes. Diabetes 38:358-363, 1989
10. Reddy S, Bibby N, Elliott RB: Longitudinal study of islet cell antibodies and development of diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 81:400-405, 1990
11. Bendelac A, Boitard C, Bedossa P, Bazin H, Bach J-F, Carnaud C: Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require treatment of host B lymphocytes. J Immunol 141:2625-2628, 1988
12. Serreze DV, Leiter EH: Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol 6:900-906, 1994
13. + T-cells to protein antigens in vivo. J Immunol 155:3734-3741, 1995
14. Jenkins MK: The ups and downs of T-cell costimulation. Immunity 1:443, 1994
15. Janeway CA Jr, Bottomly K: Signals and signs for lymphocyte responses. Cell 76:275, 1994
16. Ron Y, De Baetselier P, Gordon J, Feldman M, Segal S: Defective induction of antigen-reactive proliferating T-cells in B-cell-deprived mice. Euro J Immunol 11:964-968, 1981
17. Hayglass KT, Naides SJ, Scott CF Jr, Benacerraf B, Sy MS: T-cell development in B-cell-deficient mice. IV. The role of B-cells as antigen-presenting cells in vivo. J Immunol 136:823-829, 1986
18. Janeway CA Jr, Ron J, Katz ME: The B-cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol 138:1051-1055, 1987
19. Kurt-Jones EA, Liano D, Hay Glass KA, Benacerraf B, Sy MS, Abbas AK: The role of antigen-presenting B-cells in T-cell priming in vivo: studies of B-cell-deficient mice. J Immunol 140:3772-3778, 1988
20. Ron Y, Sprent J: T-cell priming in vivo: a major role for B-cells in presenting antigen to T-cells in lymph nodes. J Immunol 138:2848-2856, 1987
21. Katz JD, Wang B, Haskins K, Benoist C, Mathis D: Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089-1100, 1993
22. + T cell activation and tolerance induction in B-cell knockout mice. J Exp Med 183:1339-1344, 1996
23. Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P: Successful T cell priming in B-cell-deficient mice. J Exp Med 182:915-922, 1995
24. Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation. Annu Rev Immunol 7:445-480, 1989
25. Linsley PS, Ledbetter JA: The role of the CD28 receptor during T-cell responses to antigen. Annu Rev Immunol 11:191-212, 1993
26. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296, 1991
27. Cassell DJ, Schwartz RH: A quantitative analysis of antigen-presenting cell function: activated B-cells stimulate naive CD4 T-cells but are inferior to dendritic cells in providing costimulation. J Exp Med 180:1829-1840, 1994
28. Andersson A, Ekstrand-Hammarstrom B, Erikson B, Overmo C, Holmberg D: Neonatal treatment with monoclonal natural antibodies restores a normal pattern of VH gene utilization in the non-obese diabetic mouse. Int Immunol 6:623-630, 1994
29. Lanzavecchia A: How can cryptic epitopes trigger autoimmunity? J Exp Med 181:1945-1948, 1995
30. Reich E-P, von Grafenstein H, Barlow A, Swenson KE, Williams K, Janeway CA Jr Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J Immunol 152:2279-2288, 1994
31. Carrasco-Marin E, Shimizu J, Kanagawa O, Unanue ER: The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 156:450-458, 1996
32. Fulcher DA, Lyons AB, Korn SL, Cook MC, Koleda C, Parish C, Fazekas de St. Groth B, Basten A: The fate of self-reactive B-cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 183:2313-2328, 1996
33. Harada M, Makino S: Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1.2 antibody. Exp Anim 35:501-509, 1986
34. Koike T, Yojiro I, Ishii T, Ito I, Takabayashi K, Maruyama N, Toioka H, Yoshida S: Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes 36:539-541, 1987
35. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman CG: Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 420:659-662, 1988
36. Charlton B, Bacelj A, Mandel TE: Administration of silica particles or anti-Lyt2 antibody prevent β cell destruction in NOD mice given cyclophosphamide. Diabetes 37:930-935, 1988
37. + T-cells. Autoimmunity 19:187-192, 1991
38. + cells in beta cell destruction. J Autoimmunity 3:101A-109A, 1990
39. Gerling IC, Serreze DV, Christianson SW, Leiter EH: Intrathymic islet cell transplantation reduces β cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41:1672-1676, 1992
40. Andersson A, Forsgren S, Soderstrom A, Holmberg D: Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. J Autoimmun 4:733-742, 1991
41. Chen S-L, Whiteley PJ, Freed DC, Rothbard JB, Peterson LB, Wicker LS: Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide. J Autoimmun 7:635-641, 1994
42. Lehuen A, Bendelac A, Bach J-F, Carnaud C: The nonobese diabetic mouse model: independent expression of humoral and cell-mediated autoimmune features. J Immunol 144:2147-2151, 1990